{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T08:51:36Z","timestamp":1778316696974,"version":"3.51.4"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100013059","name":"Jiangsu Provincial Medical Youth Talent","doi-asserted-by":"publisher","award":["QNRC2016755"],"award-info":[{"award-number":["QNRC2016755"]}],"id":[{"id":"10.13039\/501100013059","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013059","name":"Jiangsu Provincial Medical Youth Talent","doi-asserted-by":"publisher","award":["QNRC2016770"],"award-info":[{"award-number":["QNRC2016770"]}],"id":[{"id":"10.13039\/501100013059","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018556","name":"Science and Technology Program of Suzhou","doi-asserted-by":"publisher","award":["SYS201761"],"award-info":[{"award-number":["SYS201761"]}],"id":[{"id":"10.13039\/501100018556","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018556","name":"Science and Technology Program of Suzhou","doi-asserted-by":"publisher","award":["SYS201740"],"award-info":[{"award-number":["SYS201740"]}],"id":[{"id":"10.13039\/501100018556","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81873876"],"award-info":[{"award-number":["81873876"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81701596"],"award-info":[{"award-number":["81701596"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.intimp.2018.11.053","type":"journal-article","created":{"date-parts":[[2018,12,15]],"date-time":"2018-12-15T22:52:15Z","timestamp":1544914335000},"page":"260-267","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Preparation, characterization and application of anti-human OX40 ligand (OX40L) monoclonal antibodies and establishment of a sandwich ELISA for autoimmune diseases detection"],"prefix":"10.1016","volume":"67","author":[{"given":"Jingnan","family":"An","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sisi","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lili","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanzheng","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunyun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cuiping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueguang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2018.11.053_bb0005","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/nrneph.2013.183","article-title":"Targeting co-stimulatory pathways: transplantation and autoimmunity","volume":"10","author":"Ford","year":"2014","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.intimp.2018.11.053_bb0010","doi-asserted-by":"crossref","first-page":"674","DOI":"10.2174\/1568026618666180531092503","article-title":"Toward small-molecule inhibition of protein-protein interactions: general aspects and recent progress in targeting costimulatory and coinhibitory (immune checkpoint) interactions","volume":"18","author":"Bojadzic","year":"2018","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.intimp.2018.11.053_bb0015","doi-asserted-by":"crossref","first-page":"5975","DOI":"10.4049\/jimmunol.176.10.5975","article-title":"OX40-OX40 ligand interaction through T cell-T cell contact contributes to CD4 T cell longevity","volume":"176","author":"Soroosh","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2018.11.053_bb0020","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.2741\/4265","article-title":"TNF\/TNFR: drug target for autoimmune diseases and immune-mediated inflammatory diseases","volume":"19","author":"Doss","year":"2014","journal-title":"Front. Biosci. (Landmark Ed.)"},{"key":"10.1016\/j.intimp.2018.11.053_bb0025","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1600-065X.2009.00766.x","article-title":"The significance of OX40 and OX40L to T-cell biology and immune disease","volume":"229","author":"Croft","year":"2009","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.intimp.2018.11.053_bb0030","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.immuni.2018.06.004","article-title":"Boosting type 2 immunity: when OX40L comes from ILC2s","volume":"48","author":"Babic","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2018.11.053_bb0035","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1084\/jem.20021290","article-title":"Costimulation via OX40L expressed by B cells is sufficient to determine the extent of primary CD4 cell expansion and Th2 cytokine secretion in vivo","volume":"197","author":"Linton","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2018.11.053_bb0040","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.4049\/jimmunol.159.8.3838","article-title":"Expression and function of OX40 ligand on human dendritic cells","volume":"159","author":"Ohshima","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2018.11.053_bb0045","doi-asserted-by":"crossref","first-page":"3515","DOI":"10.4049\/jimmunol.179.6.3515","article-title":"Dendritic cell expression of OX40 ligand acts as a costimulatory, not polarizing, signal for optimal Th2 priming and memory induction in vivo","volume":"179","author":"Jenkins","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2018.11.053_bb0050","doi-asserted-by":"crossref","first-page":"3940","DOI":"10.1111\/bph.13802","article-title":"Immune checkpoint proteins: exploring their therapeutic potential to regulate atherosclerosis","volume":"174","author":"Foks","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.intimp.2018.11.053_bb0055","doi-asserted-by":"crossref","first-page":"5247","DOI":"10.4049\/jimmunol.173.8.5247","article-title":"T cell proliferation by direct cross-talk between OX40 ligand on human mast cells and OX40 on human T cells: comparison of gene expression profiles between human tonsillar and lung-cultured mast cells","volume":"173","author":"Kashiwakura","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2018.11.053_bb0060","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/eji.201545879","article-title":"CD252 regulates mast cell mediated, CD1d-restricted NKT-cell activation in mice","volume":"46","author":"Gonzalez Roldan","year":"2016","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.intimp.2018.11.053_bb0065","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1084\/jem.183.5.2185","article-title":"The human OX40\/gp34 system directly mediates adhesion of activated T cells to vascular endothelial cells","volume":"183","author":"Imura","year":"1996","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2018.11.053_bb0070","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/s12016-015-8498-3","article-title":"OX40, OX40L and autoimmunity: a comprehensive review","volume":"50","author":"Webb","year":"2016","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.intimp.2018.11.053_bb0075","doi-asserted-by":"crossref","first-page":"21779","DOI":"10.18632\/oncotarget.4973","article-title":"OX40\/OX40L axis: not a friend in autoimmunity","volume":"6","author":"Ueno","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.intimp.2018.11.053_bb0080","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s00109-008-0431-2","article-title":"Association of the co-stimulator OX40L with systemic lupus erythematosus","volume":"87","author":"Manku","year":"2009","journal-title":"J. Mol. Med. (Berl.)"},{"key":"10.1016\/j.intimp.2018.11.053_bb0085","doi-asserted-by":"crossref","first-page":"4856","DOI":"10.4049\/jimmunol.1000404","article-title":"OX40 ligand regulates inflammation and mortality in the innate immune response to sepsis","volume":"185","author":"Karulf","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2018.11.053_bb0090","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/gene.2010.44","article-title":"Association of EBF1, FAM167A(C8orf13)-BLK and TNFSF4 gene variants with primary Sjogren's syndrome","volume":"12","author":"Nordmark","year":"2011","journal-title":"Genes Immun."},{"key":"10.1016\/j.intimp.2018.11.053_bb0095","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12967-018-1436-4","article-title":"OX40L induces helper T cell differentiation during cell immunity of asthma through PI3K\/AKT and P38 MAPK signaling pathway","volume":"16","author":"Huang","year":"2018","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.intimp.2018.11.053_bb0100","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1186\/s13075-014-0474-4","article-title":"Soluble OX40L is associated with presence of autoantibodies in early rheumatoid arthritis","volume":"16","author":"Laustsen","year":"2014","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.intimp.2018.11.053_bb0105","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4103\/0256-4947.75775","article-title":"OX40\/OX40L in systemic lupus erythematosus: association with disease activity and lupus nephritis","volume":"31","author":"Farres","year":"2011","journal-title":"Ann. Saudi Med."},{"key":"10.1016\/j.intimp.2018.11.053_bb0110","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/nrrheum.2017.151","article-title":"Systemic lupus erythematosus: OX40L-expressing B cells promote SLE","volume":"13","author":"McHugh","year":"2017","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.intimp.2018.11.053_bb0115","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.cyto.2006.10.006","article-title":"Development of a sandwich ELISA for evaluating soluble OX40L (CD252) in human sera of different ages or with Graves' disease","volume":"36","author":"Wang","year":"2006","journal-title":"Cytokine"},{"key":"10.1016\/j.intimp.2018.11.053_bb0120","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.intimp.2016.04.019","article-title":"Development of a novel monoclonal antibody to human inducible co-stimulator ligand (ICOSL): biological characteristics and application for enzyme-linked immunosorbent assay","volume":"36","author":"Hu","year":"2006","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2018.11.053_bb0125","first-page":"335","article-title":"Costimulatory molecules and their ligands as therapeutic targets in autoimmune disease","volume":"11","author":"Zoller","year":"2001","journal-title":"Eur. J. Dermatol."},{"key":"10.1016\/j.intimp.2018.11.053_bb0130","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/00002371-200301000-00002","article-title":"Autoantibodies against T-cell costimulatory molecules are produced in canine autoimmune diseases","volume":"26","author":"Khatlani","year":"2003","journal-title":"J. Immunother."},{"key":"10.1016\/j.intimp.2018.11.053_bb0135","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1507\/endocrj.EJ15-0435","article-title":"Association of polymorphisms in the ICOS and ICOSL genes with the pathogenesis of autoimmune thyroid diseases","volume":"63","author":"Yoshie","year":"2016","journal-title":"Endocr. J."},{"key":"10.1016\/j.intimp.2018.11.053_bb0140","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.coi.2015.01.006","article-title":"The evolution of checkpoint blockade as a cancer therapy: what's here, what's next?","volume":"33","author":"Shin","year":"2015","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.intimp.2018.11.053_bb0145","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1003466","article-title":"Improved survival with ipilimumab in patients with metastatic melanoma","volume":"363","author":"Hodi","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2018.11.053_bb0150","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.cytogfr.2008.04.003","article-title":"Immune regulation and control of regulatory T cells by OX40 and 4-1BB","volume":"19","author":"So","year":"2018","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.intimp.2018.11.053_bb0155","first-page":"4213","article-title":"Crucial role of OX40\/OX40L signaling in a murine model of asthma","volume":"17","author":"Lei","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.intimp.2018.11.053_bb0160","doi-asserted-by":"crossref","first-page":"4955","DOI":"10.1111\/bph.12819","article-title":"Small-molecule modulators of the OX40-OX40 ligand co-stimulatory protein-protein interaction","volume":"171","author":"Song","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.intimp.2018.11.053_bb0165","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1365-2567.2005.02279.x","article-title":"Activated T cells express the OX40 ligand: requirements for induction and costimulatory function","volume":"117","author":"Mendel","year":"2006","journal-title":"Immunology"},{"key":"10.1016\/j.intimp.2018.11.053_bb0170","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1378\/chest.11-1730","article-title":"OX40\/OX40 ligand interactions in T-cell regulation and asthma","volume":"141","author":"Kaur","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.intimp.2018.11.053_bb0175","first-page":"433","article-title":"An OX40\/OX40L interaction directs successful immunity to hepatitis B virus","volume":"10","author":"Publicover","year":"2018"},{"key":"10.1016\/j.intimp.2018.11.053_bb0180","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1073\/pnas.1321071111","article-title":"OX40L blockade is therapeutic in arthritis, despite promoting osteoclastogenesis","volume":"111","author":"Gwyer Findlay","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.intimp.2018.11.053_bb0185","doi-asserted-by":"crossref","first-page":"5728512","DOI":"10.1155\/2017\/5728512","article-title":"Reduced sB7-H3 expression in the peripheral blood of systemic lupus erythematosus patients","volume":"2017","author":"Sun","year":"2017","journal-title":"J Immunol Res"},{"key":"10.1016\/j.intimp.2018.11.053_bb0190","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.intimp.2012.08.004","article-title":"Increased production of circulating soluble co-stimulatory molecules CTLA-4, CD28 and CD80 in patients with rheumatoid arthritis","volume":"14","author":"Cao","year":"2013","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2018.11.053_bb0195","doi-asserted-by":"crossref","first-page":"216","DOI":"10.5114\/ceji.2014.43726","article-title":"Enhancement of soluble CD28 levels in the serum of Graves' disease","volume":"39","author":"Sun","year":"2014","journal-title":"Cent. Eur. J. Immunol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576918312530?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576918312530?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:12:28Z","timestamp":1761585148000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576918312530"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":39,"alternative-id":["S1567576918312530"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2018.11.053","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preparation, characterization and application of anti-human OX40 ligand (OX40L) monoclonal antibodies and establishment of a sandwich ELISA for autoimmune diseases detection","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2018.11.053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}